| PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma T Luo, C Loira-Pastoriza, HP Patil, B Ucakar, GG Muccioli, C Bosquillon, ... Journal of Controlled Release 239, 62-71, 2016 | 70 | 2016 |
| Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine HP Patil, S Murugappan, W Ter Veer, T Meijerhof, A De Haan, HW Frijlink, ... Journal of controlled release 174, 51-62, 2014 | 65 | 2014 |
| Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose … S Murugappan, HP Patil, G Kanojia, W ter Veer, T Meijerhof, HW Frijlink, ... European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 716-725, 2013 | 52 | 2013 |
| Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100 H Liu, HP Patil, J de Vries-Idema, J Wilschut, A Huckriede PLoS One 7 (12), e52135, 2012 | 46 | 2012 |
| Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge J Tomar, HP Patil, G Bracho, WF Tonnis, HW Frijlink, N Petrovsky, ... Journal of controlled release 288, 199-211, 2018 | 45 | 2018 |
| Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation HP Patil, D Freches, L Karmani, GA Duncan, B Ucakar, JS Suk, J Hanes, ... Journal of controlled release 272, 62-71, 2018 | 43 | 2018 |
| Antibody (IgA, IgG, and IgG subtype) responses to SARS-CoV-2 in severe and nonsevere COVID-19 patients HP Patil, PS Rane, S Shrivastava, S Palkar, S Lalwani, AC Mishra, ... Viral Immunology 34 (3), 201-209, 2021 | 30 | 2021 |
| PEGylation prolongs the pulmonary retention of an anti-IL-17A Fab’antibody fragment after pulmonary delivery in three different species D Freches, HP Patil, MM Franco, C Uyttenhove, S Heywood, R Vanbever International Journal of Pharmaceutics 521 (1-2), 120-129, 2017 | 29 | 2017 |
| Simplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine S Murugappan, HP Patil, HW Frijlink, A Huckriede, WLJ Hinrichs The AAPS journal 16, 342-349, 2014 | 27 | 2014 |
| Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration HP Patil, S Murugappan, J de Vries-Idema, T Meijerhof, A de Haan, ... European Journal of Pharmaceutics and Biopharmaceutics 93, 231-241, 2015 | 25 | 2015 |
| Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination J Tomar, WF Tonnis, HP Patil, P Hagedoorn, R Vanbever, HW Frijlink, ... Acta Pharmaceutica Sinica B 9 (6), 1231-1240, 2019 | 22 | 2019 |
| Evaluation of mucosal and systemic immune responses elicited by GPI-0100-adjuvanted influenza vaccine delivered by different immunization strategies H Liu, HP Patil, J de Vries-Idema, J Wilschut, A Huckriede PLoS One 8 (7), e69649, 2013 | 22 | 2013 |
| Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy MJ Guichard, HP Patil, SJ Koussoroplis, R Wattiez, T Leal, R Vanbever International journal of pharmaceutics 524 (1-2), 159-167, 2017 | 20 | 2017 |
| Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA R Kulkarni, HP Patil, S Palkar, S Lalwani, AC Mishra, V Arankalle Journal of Virological Methods 287, 113996, 2021 | 17 | 2021 |
| Standardization of ELISA for anti-chikungunya-IgG antibodies and age-stratified prevalence of anti-chikungunya-IgG antibodies in Pune, India HP Patil, PS Rane, M Gosavi, AC Mishra, VA Arankalle European Journal of Clinical Microbiology & Infectious Diseases 39, 1925-1932, 2020 | 11 | 2020 |
| Adjuvantation of pulmonary-administered influenza vaccine with GPI-0100 primarily stimulates antibody production and memory B cell proliferation HP Patil, J Herrera Rodriguez, J de Vries-Idema, T Meijerhof, HW Frijlink, ... Vaccines 5 (3), 19, 2017 | 9 | 2017 |
| PEGylation of Recombinant Human Deoxyribonuclease I Provides a Long‐Acting Version of the Mucolytic for Patients with Cystic Fibrosis MJ Guichard, T Wilms, S Mahri, HP Patil, D Hoton, B Ucakar, ... Advanced Therapeutics 4 (2), 2000146, 2021 | 7 | 2021 |
| Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad S Shrivastava, HP Patil, ST Mhaske, S Palkar, S Lalwani, AC Mishra, ... Virus Genes 57, 245-249, 2021 | 6 | 2021 |
| Age-dependent evaluation of immunoglobulin G response after chikungunya virus infection HP Patil, M Gosavi, AC Mishra, VA Arankalle The American Journal of Tropical Medicine and Hygiene 104 (4), 1438, 2021 | 6 | 2021 |
| Preclinical evaluation of topically-administered PEGylated Fab’lung toxicity D Freches, N Rocks, HP Patil, F Perin, J Van Snick, R Vanbever, ... International Journal of Pharmaceutics: X 1, 100019, 2019 | 6 | 2019 |
